BioInsights
Applonia Rose, PhD, currently serves as Managing Editor at Sage since May 2021, overseeing the Technology in Cancer Research & Treatment journal with an impact factor of 2.8. Since May 2016, Applonia has also been a Commissioning Editor at BioInsights, focusing on content development, peer review management, and quality assurance. Prior experience includes working as a Review Commissioner at Dove Medical Press from August 2014 to 2016, where Applonia commissioned review articles for various reputable journals. Applonia's academic background includes a PhD in Biomedical Sciences from KU Leuven, where the doctoral thesis focused on cell biology and molecular genetics, as well as a predoctorate degree in the same field. Additional educational qualifications include a Short Course on Drug Regulatory Affairs from King's College London and a Master of Science in Biotechnology from Kannur University. Applonia holds a Bachelor of Science in Microbiology from St. Pius X College.
This person is not in any teams
BioInsights
BioInsights was founded with the vision of publishing high-quality research and commentary in areas of bioscience that offer true potential to revolutionize modern healthcare. Our peer-reviewed, open access publications include Cell and Gene Therapy Insights, Immuno-Oncology Insights, Vaccine Insights and - our newest journal - Nucleic Acid Insights. Our publications provide rapid analysis of cutting-edge technological advances and facilitate debate and discussion by all stakeholders committed to progressing clinical translation and commercialization in these exciting fields. Register at www.insights.bio for free access to original research, review, commentary, and interview articles, as well as webinars and video roundtables.